Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

Clinical trial NCT07061769 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07061769
Sponsor: FluxWear, INC
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Chemotherapy Induced Peripheral Neuropathy Chemotherapy Induced Peripheral Neuropathy (CIPN)Chemotherapy Induced Pain Neuropathy Chemotherapy Induced Neuropathic Pain

Start date: 2025-06-23
Primary completion: 2026-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.